Tell Congress to Stop the “Most Favored Nation” Price Setting Proposal
The Trump Administration is considering a “Most Favored Nation” price setting proposal for Medicaid in the reconciliation bill. The proposed policy will result in a one trillion dollar hit to the biopharmaceutical industry, which would negatively impact research, jobs, and most importantly, American patients. Contact your members of Congress now and urge them to oppose the “Most Favored Nation” price setting policy for Medicaid and consider other actions to lower the cost of prescription drugs in America.